Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011767
Filing Date
2025-05-02
Accepted
2025-05-02 16:02:32
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05022025_080528.html 4  
1 form4-05022025_080528.xml 4 5937
  Complete submission text file 0001415889-25-011767.txt   7578
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VISTERRA, INC. ONE KENDALL SQUARE, #B3301 CAMBRIDGE MA 02139
Business Address
Connaughton Bernadette (Reporting) CIK: 0001662521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 25908330